Down Syndrome Candidate Region 1,a Downstream Target of VEGF, Participa tes in Endothelial Cell Migration and Angiogenesis
- 1 August 2004
- journal article
- research article
- Published by S. Karger AG in Journal of Vascular Research
- Vol. 41 (4) , 334-344
- https://doi.org/10.1159/000079832
Abstract
Vascular endothelial growth factor (VEGF) is a principal stimulator of angiogenesis. However, the downstream targets of VEGF in endothelial cells (ECs) are not entirely clarified. Survey of downstream targets of VEGF in human ECs identified a number of genes, including Down syndrome candidate region 1 (DSCR1). Here, we confirmed the inducible expression of DSCR1 in ECs by Northern and Western blottings. Moreover, VEGF-stimulated induction of DSCR1 was blocked by anti-VEGF receptor-2 monoclonal antibody (mAb), or the specific calcineurin inhibitors cyclosporin A and FK506. The expression of DSCR1 in ECs of neovessels was further shown by immunohistochemical analysis. We therefore examined whether DSCR1 played any roles in angiogenesis. The specific downregulation of DSCR1 expression by antisense oligonucleotide (AS-ODN) inhibited VEGF-stimulated migration of ECs as well as angiogenesis in vivo. AS-ODN inhibited the spreading of ECs on vitronectin, as well as on the immobilized anti-αvβ3 mAb, but not on anti-αvβ5 mAb. Moreover, AS-ODN inhibited tyrosine phosphorylation of focal adhesion kinase when ECs were plated on a vitronectin-coated dish. Immunoprecipitation followed by Western blotting showed the coimmunoprecipitation of DSCR1 and integrin αvβ3. These results suggest that DSCR1 is involved in angiogenesis by regulating adhesion and migration of ECs via the interaction with integrin αvβ3.Keywords
This publication has 30 references indexed in Scilit:
- Vascular smooth muscle cell growth‐promoting factor/F‐spondin inhibits angiogenesis via the blockade of integrin αvβ3 on vascular endothelial cellsJournal of Cellular Physiology, 2001
- Calcium, Calcineurin, and the Control of TranscriptionJournal of Biological Chemistry, 2001
- Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular DomainJournal of Biological Chemistry, 2000
- Vascular Endothelial Growth Factor Activates STAT Proteins in Aortic Endothelial CellsJournal of Biological Chemistry, 2000
- Properties of Two VEGF Receptors, Flt‐1 and KDR, in Signal TransductionaAnnals of the New York Academy of Sciences, 2000
- Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cellsOncogene, 2000
- A New Gene Family Including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: Characterization from Yeast to Human and Identification of DSCR1-like 2, a Novel Human Member (DSCR1L2)Genomics, 2000
- VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cellsOncogene, 1999
- A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heartHuman Molecular Genetics, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994